The nation of Zimbabwe has rejected a major American health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' request for confidential information.
This rejection was revealed after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman later stated that the US was demanding access to biological samples for research and commercial gain while was unwilling to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more dialogue to find a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court halted a related deal with the US following concerns were filed about the security of Kenyans' health data.
After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
According to statements, 16 nations in Africa have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"In essence, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a future disease outbreak emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures already set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.
"This mechanism is intended to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations must proceed given that much of the country's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
This impasse emphasises the ongoing tensions between accepting vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.